secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch Health Companies Inc. (BHC)
CIK:        0000885590
Form:       8-K
Filed at:   2025-12-12T23:59:59+00:00
Accession:  0000950103-25-016089
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch + Lomb refinances $2.8B term loans; margin cut, maturity extended to 2031
--------------------------------------------------------------------------------

- $2.802B new Replacement Term Loans to refinance existing term B loans due 2028 and 2031.
- Applicable margin reduced by 0.50% (to 3.75%+SOFR) for Third Amendment loans and 0.25% (to 2.75%+ABR) for First Incremental loans.
- Maturity extended for First Incremental loans from Sep 29, 2028 to Jan 15, 2031; Third Amendment loans unchanged at 2031.
- Transaction expected to close in Q1 2026, subject to conditions; no assurance of completion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885590/000095010325016089/0000950103-25-016089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885590/000095010325016089/dp238710_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-25-016089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer